Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals
Anahit Mkrtchian, Jennifer W. Evans, Christoph Kraus, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 3292-3301
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
Ioline D. Henter, Lawrence T. Park, Carlos A. Zarate
CNS Drugs (2021) Vol. 35, Iss. 5, pp. 527-543
Open Access | Times Cited: 108
Toward a Better Understanding of the Mechanisms and Pathophysiology of Anhedonia: Are We Ready for Translation?
Diego A. Pizzagalli
American Journal of Psychiatry (2022) Vol. 179, Iss. 7, pp. 458-469
Open Access | Times Cited: 93
Functional connectomics in depression: insights into therapies
Ya Chai, Yvette I. Sheline, Desmond J. Oathes, et al.
Trends in Cognitive Sciences (2023) Vol. 27, Iss. 9, pp. 814-832
Open Access | Times Cited: 47
Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 47
Roles of the medial and lateral orbitofrontal cortex in major depression and its treatment
Bei Zhang, Edmund T. Rolls, Xiang Wang, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 4, pp. 914-928
Closed Access | Times Cited: 46
Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
Yuan Yao, Dan Guo, Tangsheng Lu, et al.
Psychiatry Research (2024) Vol. 335, pp. 115886-115886
Closed Access | Times Cited: 23
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)
Mauro Pettorruso, Roberto Guidotti, Giacomo d’Andrea, et al.
Psychiatry Research (2023) Vol. 327, pp. 115378-115378
Open Access | Times Cited: 22
The anterior cingulate cortex as a key locus of ketamine’s antidepressant action
Laith Alexander, Luke A. Jelen, Mitul A. Mehta, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 531-554
Open Access | Times Cited: 50
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
Michael J. Colwell, Hosana Tagomori, Sarah Chapman, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
Brandon Taraku, Roger P. Woods, Michael Boucher, et al.
Human Brain Mapping (2023) Vol. 44, Iss. 6, pp. 2395-2406
Open Access | Times Cited: 16
Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review
Johanna Louise Keeler, Janet Treasure, Mário F. Juruena, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 4158-4158
Open Access | Times Cited: 38
Understanding complex functional wiring patterns in major depressive disorder through brain functional connectome
Zhiyun Yang, Lingyu Jian, Hui Qiu, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 37
Pleasure, Reward Value, Prediction Error and Anhedonia
Karel Kieslich, Vincent Valton, Jonathan P. Roiser
Current topics in behavioral neurosciences (2022), pp. 281-304
Closed Access | Times Cited: 25
Bridging the gap: (a)typical psychedelic and near-death experience insights
Pauline Fritz, Nicolas Lejeune, Paolo Cardone, et al.
Current Opinion in Behavioral Sciences (2024) Vol. 55, pp. 101349-101349
Open Access | Times Cited: 4
Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review
Aleksander Kwaśny, Julia Kwaśna, Alina Wilkowska, et al.
European Neuropsychopharmacology (2024) Vol. 86, pp. 20-34
Closed Access | Times Cited: 4
Eficácia da cetamina e esketamina no tratamento da depressão: revisão das evidências e perspectivas futuras
RAPHAELA NOGUEIRA DUTRA, Mario Vitor Ferreira Nascimento, João Pedro Silva Gontijo, et al.
STUDIES IN HEALTH SCIENCES (2025) Vol. 6, Iss. 1, pp. e14206-e14206
Closed Access
Ketamine rescues anhedonia by cell-type- and input-specific adaptations in the nucleus accumbens
Federica Lucantonio, Jacob Roeglin, Shuwen Li, et al.
Neuron (2025)
Open Access
An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
Sherry-Anne Muscat, Glenn Hartelius, Courtenay Crouch, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 28
Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review
Ilya Demchenko, Vanessa K. Tassone, Sidney H. Kennedy, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 21
A unified model of ketamine’s dissociative and psychedelic properties
M. Marguilho, I. Figueiredo, Pedro Castro-Rodrigues
Journal of Psychopharmacology (2022) Vol. 37, Iss. 1, pp. 14-32
Open Access | Times Cited: 20
Apathy and Motivation: Biological Basis and Drug Treatment
Harry Costello, Masud Husain, Jonathan P. Roiser
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 313-338
Open Access | Times Cited: 11
Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies
Gustavo C. Medeiros, Malcolm Matheson, Isabella Demo, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 10, pp. 790-800
Closed Access | Times Cited: 11
A translational perspective on the anti-anhedonic effect of ketamine and its neural underpinnings
Erdem Pulcu, Calum Guinea, Philip J. Cowen, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 81-87
Open Access | Times Cited: 24
Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review
Breno Souza‐Marques, Cassio Santos‐Lima, Lucas Araújo-de-Freitas, et al.
Harvard Review of Psychiatry (2021) Vol. 29, Iss. 5, pp. 340-350
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top